Skip to content

Globus Medical GMED Common Stock Shares Outstanding

Common Stock Shares Outstanding at other companies

Our Bond, Inc.
 logo
Our Bond, Inc. OBAI
21.1M
EFC
Ellington Financial Inc.EFC
18.4K+9.8%
Jaguar Uranium
 logo
Jaguar Uranium JAGU
1
Corvex
 logo
Corvex MOVE
20%
Popular logo
PopularBPOP
Popular logo
PopularBPOP

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's common stock shares outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's common stock shares outstanding?
Globus Medical (GMED) reported common stock shares outstanding of $250.92M in Q1 2026.
How has Globus Medical's common stock shares outstanding changed year-over-year?
Globus Medical's common stock shares outstanding increased by 34.9% year-over-year, from $186.07M to $250.92M.
What is the long-term trend for Globus Medical's common stock shares outstanding?
Over 4 years (2020 to 2024), Globus Medical's common stock shares outstanding has grown at a 6.4% compound annual growth rate (CAGR), from $232.81M to $298.6M.